The effects of polypeptide complex from the kidney and short peptides AED, EDL, and AEDG on renal functions were studied in rats with cisplatin-induced acute renal failure. AED peptide decreased protein excretion and electrolyte concentration in the urine. Polypeptide complex from the kidney and peptides EDL and AEDG normalized diuresis, creatinine concentration in the urine and its excretion, glomerular filtration rate, and absolute resorption of sodium ions and reduced protein concentration in the urine and its excretion, the concentrations of sodium and potassium ions in the urine, and other parameters. EDL peptide produced was potent nephroprotective effect. It is known that the polypeptide complex of the kidney and short peptides restore the expression of signal molecules (marker of functional state of the kidneys), so these peptide substances can have nephroprotective effect during various renal pathologies.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
A. I. Gozhenko, Patologiya, 5, No. 3, 66-75 (2008).
V. V. Khavinson, V. V. Malinin, and G. A. Ryzhak, Eurasian Patent No. 010723, Substance Normalizing Renal Function and Method of Its Synthesis, October 30, 2008.
V. S. Kamyshnikova, Manual for Clinical and Biochemical Analysis and Laboratory Diagnostics [in Russian], Moscow (2009).
T. E. Nichuk, N. S. Lin’kova, N. A. Kraskovskaya, et al., Uspekhi Fiziol. Nauk, 45, No. 2, 49-56 (2014).
O. O. Petyuk, N. I. Voloshchuk, and O. V. Mashevs’ka, Rats. Farmakoter., No. 1, 6-15 (2009).
S. I. Ryabov and Yu. V. Natochkin, Functional Neurology [in Russian], St. Petersburg (1997).
V. Kh. Khavintson, N. S. Lin’kova, V. O. Polyakova, et al., Bull. Exp. Biol. Med., 157, No. 2, 261-264 (2014).
S. Yu. Schtrigol’, V. M. Lisovii, and I. A. Zupanen’, Methods for Experimental Modeling of Kidney Failure in Pharmacological Studies [in Ukrainian], Kiev (2009).
V. Kh. Khavinson, N. S. Linkova, A. V. Trofimov, et al., Biol. Bull. Rev., 1, No. 4, 389-393 (2011).
U. Kilic, E. Kilic, Z. Tuzcu, et al., Nutr. Metab. (Lond.), 10, No. 1, 7 (2013).
R. P. Miller, R. K. Tadagavadi, G. Ramesh, and W. B. Reeves, Toxins (Basel), 2, No. 11, 2490-2518 (2010).
N. Pabla, and Z. Dong, Kidney Int., 73, No. 9, 994-1007 (2008).
A. P. Singh, A. Junemann, A. Muthuraman, et al., Pharmacol. Rep., 64, No. 1, 31-44 (2012).
X. Yao, K. Panichpisal, N. Kurtzman, and K. Nugent, Am. J. Med. Sci., 334, No. 2, 115-124 (2007).
I. I. Zamorskii, and T. S. Shchudrova, Biophysics, 59, No. 5, 834-836 (2014).
Author information
Authors and Affiliations
Corresponding authors
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 159, No. 6, pp. 708-713, June, 2015
Rights and permissions
About this article
Cite this article
Zamorskii, I.I., Shchudrova, T.S., Lin’kova, N.S. et al. Peptides Restore Functional State of the Kidneys During Cisplatin-Induced Acute Renal Failure. Bull Exp Biol Med 159, 736–739 (2015). https://doi.org/10.1007/s10517-015-3062-y
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-015-3062-y